March 07, 2014

Frank’s New England Journal of Medicine Letter

I am pleased to share to with you my letter-to-the-editor from the Feb 20th, issue of NEJM (p 781). I responded to a Nov 14th, National Heart, Lung, and Blood Institute report that studies with clinical endpoints were published faster than those with surrogate outcomes. IMHO, NHLBI missed a teachable moment to show which journals were most likely to accept clinical vs. surrogate outcomes, thus contributing to better first acceptance and time-to-publication. The NEJM editors and NHLBI authors agreed!

NEJM Rodino 20 Feb 2014.pdf